[The picture of visual evoked potentials in type 1 diabetes mellitus]. 2005

Dariusz A Szabela, and Jerzy Loba, and Dorota Pałenga-Pydyn, and Krzysztof Tybor, and Jan Ruxer, and Wojciech Split
Z Zakładu Medycyny Fizykalnej Katedry Rehabilitaci Uniwersytetu Medycznego w Lodzi.

The aim of this study was to assess frequency of abnormal visual evoked potentials in type 1 diabetic patients and the correlation between patients' age, duration of the disease, metabolic control and coexisting clinical complications on the abnormal recordings. The investigation was carried out in a group of 50 diabetic patients, aged from 16 to 55 years. The VEP recordings were performed four times, each time using a pattern made up of elements of another size (18, 36, 72 and 144 angular minutes). With this method the abnormal VEP were recorded in 26% of the cases and it was possible to find 10% patients who had more than one abnormal test. In VEP recorded with stimulation with a single size pattern, abnormal results were recorded from 8% to 14% of the cases. The pathological VEP were recorded as elongation of P100 latency in 86% type 1 diabetic patients, and as significant difference between the latencies from both eyes in 14% cases. There was no statistically significant correlation between the age, duration of the disease, coexisting clinical complications or metabolic compensation and the abnormal recordings.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003930 Diabetic Retinopathy Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION. Diabetic Retinopathies,Retinopathies, Diabetic,Retinopathy, Diabetic
D005074 Evoked Potentials, Visual The electric response evoked in the cerebral cortex by visual stimulation or stimulation of the visual pathways. Visual Evoked Response,Evoked Potential, Visual,Evoked Response, Visual,Evoked Responses, Visual,Potential, Visual Evoked,Potentials, Visual Evoked,Response, Visual Evoked,Responses, Visual Evoked,Visual Evoked Potential,Visual Evoked Potentials,Visual Evoked Responses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Dariusz A Szabela, and Jerzy Loba, and Dorota Pałenga-Pydyn, and Krzysztof Tybor, and Jan Ruxer, and Wojciech Split
March 1988, Acta neurologica Scandinavica,
Dariusz A Szabela, and Jerzy Loba, and Dorota Pałenga-Pydyn, and Krzysztof Tybor, and Jan Ruxer, and Wojciech Split
July 2012, Journal of ophthalmic & vision research,
Dariusz A Szabela, and Jerzy Loba, and Dorota Pałenga-Pydyn, and Krzysztof Tybor, and Jan Ruxer, and Wojciech Split
January 2022, Kathmandu University medical journal (KUMJ),
Dariusz A Szabela, and Jerzy Loba, and Dorota Pałenga-Pydyn, and Krzysztof Tybor, and Jan Ruxer, and Wojciech Split
January 2005, Neurologia i neurochirurgia polska,
Dariusz A Szabela, and Jerzy Loba, and Dorota Pałenga-Pydyn, and Krzysztof Tybor, and Jan Ruxer, and Wojciech Split
July 1992, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,
Dariusz A Szabela, and Jerzy Loba, and Dorota Pałenga-Pydyn, and Krzysztof Tybor, and Jan Ruxer, and Wojciech Split
January 1997, Clinical neuroscience (New York, N.Y.),
Dariusz A Szabela, and Jerzy Loba, and Dorota Pałenga-Pydyn, and Krzysztof Tybor, and Jan Ruxer, and Wojciech Split
December 2012, Archives italiennes de biologie,
Dariusz A Szabela, and Jerzy Loba, and Dorota Pałenga-Pydyn, and Krzysztof Tybor, and Jan Ruxer, and Wojciech Split
January 1994, Neurologia i neurochirurgia polska,
Dariusz A Szabela, and Jerzy Loba, and Dorota Pałenga-Pydyn, and Krzysztof Tybor, and Jan Ruxer, and Wojciech Split
July 2002, Documenta ophthalmologica. Advances in ophthalmology,
Dariusz A Szabela, and Jerzy Loba, and Dorota Pałenga-Pydyn, and Krzysztof Tybor, and Jan Ruxer, and Wojciech Split
January 1992, Journal of the Formosan Medical Association = Taiwan yi zhi,
Copied contents to your clipboard!